Ormat‘s Viridity to Begin Construction of 40MWh Energy Storage Systems in New Jersey
Apr 16, 2018 21:00 pm UTC| Business
RENO, Nev., April 16, 2018 -- Ormat Technologies, Inc. (NYSE:ORA) announced that its wholly owned subsidiary, Viridity Energy Solutions, Inc., a leading battery storage, distributed generation, demand response, and...
Paramount Gold Nevada Corp. to Present at the European Gold Forum in Zurich
Apr 16, 2018 21:00 pm UTC| Business
WINNEMUCCA, Nev., April 16, 2018 -- Paramount Gold Nevada Corp. (NYSE American:PZG) ("Paramount”) announced today that its CEO, Glen Van Treek will be presenting at the European Gold Forum on Thursday April 19, 2018 at...
QIWI Announces 2018 Annual General Meeting
Apr 16, 2018 21:00 pm UTC| Business
NICOSIA, Cyprus, April 16, 2018 -- QIWI plc (Nasdaq:QIWI), (MOEX:QIWI) ("QIWI" or the "Company") today announced that its 2018 annual general meeting of shareholders (the "AGM") will be held on Monday June 4, 2018, at...
Apr 16, 2018 21:00 pm UTC| Business
NEW YORK, April 16, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Patterson Companies, Inc. (NASDAQ:PDCO) who purchased shares between June 26, 2015 and...
Cardtronics Announces First Quarter 2018 Earnings Release Date and Conference Call Information
Apr 16, 2018 20:55 pm UTC| Business
HOUSTON, April 16, 2018 -- Cardtronics plc (NASDAQ:CATM), the world's largest ATM owner / operator, announced today that it has scheduled a conference call on Thursday, May 3, 2018, at 4:00 p.m. CDT (5:00 p.m. EDT) to...
AMD to Report Fiscal First Quarter 2018 Financial Results
Apr 16, 2018 20:50 pm UTC| Business
SANTA CLARA, Calif., April 16, 2018 -- AMD (NASDAQ:AMD) announced today that it will report first quarter 2018 financial results on Wednesday, Apr. 25, 2018 after the close of market. Management will conduct a...
Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 16, 2018 20:42 pm UTC| Business
HOUSTON, April 16, 2018 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood...